ATLASCNS Pharmaceuticals (CNSP) earnings date: Nov 13, 2026
CNS Pharmaceuticals (CNSP) reports earnings for the quarter ended Sep 30, 2026 on Fri, Nov 13, 2026.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on CNSP
| Last price | $4.39 (-12.2%) |
|---|---|
| Normal 1-day range (±1σ) | ±5.6% |
| Earnings beat history | Beat the EPS estimate in 1 of the last 4 reports |
These figures come from the same calibrated model and valuation as the CNS Pharmaceuticals stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
CNS Pharmaceuticals reports on Nov 13, 2026. One email the day before, with ATLAS’s read on CNS Pharmaceuticals. You can switch it off at any time.
Alert me before CNSP reportsFree to start. Creating an account takes under a minute.
Notify me when CNS Pharmaceuticals reports
Track CNSP free Add CNS Pharmaceuticals to a free ATLAS watchlist and see its next report date in one place.
CNSP earnings at a glance
| Next report (confirmed) | Fri, Nov 13, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| Last report | Aug 12, 2026 · Miss |
| Beat rate (last 4 reports) | 1 of 4 (25%) |
| Average EPS surprise | -47.3% |
| Average move around a report | ±6.8% (last 4) |
| Sector | Healthcare · Biotechnology |
CNS Pharmaceuticals earnings history: last 4 reports
CNS Pharmaceuticals last reported on Aug 12, 2026: EPS of -$0.38 against an estimate of -$0.24 (-58.3% surprise), a miss.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 12, 2026 | -$0.24 | -$0.38 | -58.3% | Miss | +0.4% |
| Jul 30, 2026 | $2.51 | $2.62 | +4.4% | Beat | +16.3% |
| May 14, 2026 | -$5.37 | -$7.30 | -35.9% | Miss | -10.3% |
| Mar 31, 2026 | -$5.09 | -$10.15 | -99.4% | Miss | +0.2% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for CNSP
See the fair value, the probability range and the earnings history of CNS Pharmaceuticals on its ATLAS page.
CNS Pharmaceuticals (CNSP) stock analysisPlans from €3.99 a month.
CNS Pharmaceuticals earnings: frequently asked questions
When does CNS Pharmaceuticals (CNSP) report earnings?
CNS Pharmaceuticals is scheduled to report on Friday, November 13, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
How often does CNSP beat earnings estimates?
Of its last 4 reports with a recorded result, CNS Pharmaceuticals beat the EPS estimate 1 times; the average surprise was -47.3%. Past results do not predict the next one.
How much does CNSP move around earnings?
Over its last 4 reports the stock moved an average of 6.8% (absolute, from the close before the report day to the close after it), and finished higher 3 of 4 times.
Did CNS Pharmaceuticals beat earnings estimates last quarter?
CNS Pharmaceuticals last reported on Aug 12, 2026: EPS of -$0.38 against an estimate of -$0.24 (-58.3% surprise), a miss.
How much does CNSP usually move in a day?
On a normal trading day the ATLAS model puts CNSP’s one-day range at about ±5.6%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Fri, Nov 13, 2026
Educational information, not investment advice. Disclaimer